We manage the translation of an idea into practice, working with academic inventors throughout the process of commercialisation, leading ultimately to licensing to industry partners, or the creation of new ventures.Find out more
We work to develop new company opportunities based on leading UK academic research, working with Imperial College London (& our own Technology Transfer team), The Universities of Oxford & Cambridge and UCL.Find out more
£25m Series A for Cambridge-based biotech focused on novel DDR cancer therapiesRead article
We have identified four particular areas of expertise, shown in the diagram below. As at 31 July 2016, the value of the top 10 investments in our portfolio stood at £202.5 million while our total portfolio was valued at £335.1 million.
Using Xenon to prevent neuronal damage
Internet of Things solutions provider specialising in fully integrated business solutions around connected product intelligence.
Sector: Financial Services
Activities: Technology commercialisation, incubation and investment
Year end: 31 July